Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Haffner

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
Pediatric Nephrology (Berlin, Germany)|December 12, 2019
Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levelsDieter Haffner, Maren Leifheit-Nestler
Pediatric Nephrology (Berlin, Germany)|December 21, 2019
CKD-MBD post kidney transplantationDieter Haffner, Maren Leifheit-Nestler
Pediatric Nephrology (Berlin, Germany)|January 27, 2011
Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Dieter Haffner, Dagmar-Christiane Fischer
Kidney International|April 20, 2025
Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?Dieter Haffner, Maren Leifheit-Nestler
Pediatric Nephrology (Berlin, Germany)|June 5, 2009
Nephrotic syndrome and rituximab: facts and perspectivesDieter Haffner, Dagmar-Christiane Fischer
Molecular and Cellular Pediatrics|September 18, 2021
How FGF23 shapes multiple organs in chronic kidney diseaseMaren Leifheit-Nestler, Dieter Haffner
Kidney International|March 21, 2025
The authors replyMax Brunkhorst, Dieter Haffner, Francesco Emma
Klinische Monatsblatter Fur Augenheilkunde|March 28, 2023
CystinosisKatharina Hohenfellner, Kirstin Zerell, Dieter Haffner
Journal of Medical Case Reports|September 30, 2011
Non-small cell lung carcinoma in an adolescent manifested by acute paraplegia due to spinal metastases: a case reportUlrike Ackert, Dieter Haffner, Carl Friedrich Classen
Toxins|November 9, 2019
FGF23 and Phosphate-Cardiovascular Toxins in CKDIsabel Vogt, Dieter Haffner, Maren Leifheit-Nestler
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Pediatric Nephrology (Berlin, Germany)|December 12, 2019
Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levelsDieter Haffner, Maren Leifheit-Nestler
Pediatric Nephrology (Berlin, Germany)|December 21, 2019
CKD-MBD post kidney transplantationDieter Haffner, Maren Leifheit-Nestler
Pediatric Nephrology (Berlin, Germany)|January 27, 2011
Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Dieter Haffner, Dagmar-Christiane Fischer
Kidney International|April 20, 2025
Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?Dieter Haffner, Maren Leifheit-Nestler
Pediatric Nephrology (Berlin, Germany)|June 5, 2009
Nephrotic syndrome and rituximab: facts and perspectivesDieter Haffner, Dagmar-Christiane Fischer
Molecular and Cellular Pediatrics|September 18, 2021
How FGF23 shapes multiple organs in chronic kidney diseaseMaren Leifheit-Nestler, Dieter Haffner
Kidney International|March 21, 2025
The authors replyMax Brunkhorst, Dieter Haffner, Francesco Emma
Klinische Monatsblatter Fur Augenheilkunde|March 28, 2023
CystinosisKatharina Hohenfellner, Kirstin Zerell, Dieter Haffner
Journal of Medical Case Reports|September 30, 2011
Non-small cell lung carcinoma in an adolescent manifested by acute paraplegia due to spinal metastases: a case reportUlrike Ackert, Dieter Haffner, Carl Friedrich Classen
Toxins|November 9, 2019
FGF23 and Phosphate-Cardiovascular Toxins in CKDIsabel Vogt, Dieter Haffner, Maren Leifheit-Nestler
Pageof 25